Academic Journal

Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.

التفاصيل البيبلوغرافية
العنوان: Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
المؤلفون: Chaix, J., Pellet, J., Frobert, L., Fankhauser, C., Ismailaj, A., Brana, A., Tamic, G., Suter, C., Rexhaj, S.
المصدر: Psychotherapy and psychosomatics, vol. 88, no. 2, pp. 84-95
سنة النشر: 2019
المجموعة: Université de Lausanne (UNIL): Serval - Serveur académique lausannois
مصطلحات موضوعية: Adult, Anhedonia, Apathy, Cognitive Behavioral Therapy, Female, Humans, Male, Motivation, Pleasure, Psychiatric Status Rating Scales, Schizophrenia/complications, Schizophrenia/therapy, Schizophrenic Psychology, Treatment Outcome, Negative symptoms, Positive psychology, Randomized controlled trial, Schizophrenia
الوصف: Negative symptoms are frequent in patients with schizophrenia and are associated with marked impairments in social functioning. The efficacy of drug-based treatments and psychological interventions on primary negative symptoms remains limited. The Positive Emotions Programme for Schizophrenia (PEPS) is designed to improve pleasure and motivation in schizophrenia patients by targeting emotion regulation and cognitive skills relevant to apathy and anhedonia. The main hypothesis of this study is that patients who attend 8 one-hour sessions of PEPS and treatment as usual (TAU) will have lower total apathy-avolition and anhedonia-asociality composite scores on the Scale for the Assessment of Negative Symptoms (SANS) than patients who attend only TAU. Eighty participants diagnosed with schizophrenia or schizoaffective disorder were randomized to receive either TAU or PEPS + TAU. The participants were assessed by independent evaluators before randomization (T0), in a post-test after 8 weeks of treatment (T1) and at a 6-month follow-up (T2). The post-test results and 6-month follow-up assessments according to an intention-to-treat analysis showed that the apathy and anhedonia composite scores on the SANS indicated statistically greater clinical improvements in PEPS participants than in non-PEPS participants. In the post-test, anhedonia but not apathy was significantly improved, thus favouring the PEPS condition. These results were sustained at the 6-month follow-up. PEPS is an effective intervention to reduce anhedonia in schizophrenia. PEPS is a short, easy-to-use, group-based, freely available intervention that is easy to implement in a variety of environments (ClinicalTrials.gov ID: NCT02593058).
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/30783071; info:eu-repo/semantics/altIdentifier/eissn/1423-0348; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_53DCAB64149F1; https://serval.unil.ch/notice/serval:BIB_53DCAB64149F; https://www.karger.com/Article/FullText/496479; https://serval.unil.ch/resource/serval:BIB_53DCAB64149F.P002/REF.pdf
DOI: 10.1159/000496479
الاتاحة: https://serval.unil.ch/notice/serval:BIB_53DCAB64149F
https://doi.org/10.1159/000496479
https://www.karger.com/Article/FullText/496479
https://serval.unil.ch/resource/serval:BIB_53DCAB64149F.P002/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_53DCAB64149F1
Rights: info:eu-repo/semantics/openAccess ; CC BY-NC-ND 4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.8622C361
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.8622C361
893
3
Academic Journal
academicJournal
892.664306640625
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.8622C361&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://serval.unil.ch/notice/serval:BIB_53DCAB64149F# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Chaix%2C+J%2E%22">Chaix, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Pellet%2C+J%2E%22">Pellet, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Frobert%2C+L%2E%22">Frobert, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Fankhauser%2C+C%2E%22">Fankhauser, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Ismailaj%2C+A%2E%22">Ismailaj, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Brana%2C+A%2E%22">Brana, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Tamic%2C+G%2E%22">Tamic, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Suter%2C+C%2E%22">Suter, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Rexhaj%2C+S%2E%22">Rexhaj, S.</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Psychotherapy and psychosomatics, vol. 88, no. 2, pp. 84-95 )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Université de Lausanne (UNIL): Serval - Serveur académique lausannois )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Anhedonia%22">Anhedonia</searchLink><br /><searchLink fieldCode="DE" term="%22Apathy%22">Apathy</searchLink><br /><searchLink fieldCode="DE" term="%22Cognitive+Behavioral+Therapy%22">Cognitive Behavioral Therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Motivation%22">Motivation</searchLink><br /><searchLink fieldCode="DE" term="%22Pleasure%22">Pleasure</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+Status+Rating+Scales%22">Psychiatric Status Rating Scales</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%2Fcomplications%22">Schizophrenia/complications</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%2Ftherapy%22">Schizophrenia/therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenic+Psychology%22">Schizophrenic Psychology</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink><br /><searchLink fieldCode="DE" term="%22Negative+symptoms%22">Negative symptoms</searchLink><br /><searchLink fieldCode="DE" term="%22Positive+psychology%22">Positive psychology</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trial%22">Randomized controlled trial</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Negative symptoms are frequent in patients with schizophrenia and are associated with marked impairments in social functioning. The efficacy of drug-based treatments and psychological interventions on primary negative symptoms remains limited. The Positive Emotions Programme for Schizophrenia (PEPS) is designed to improve pleasure and motivation in schizophrenia patients by targeting emotion regulation and cognitive skills relevant to apathy and anhedonia. The main hypothesis of this study is that patients who attend 8 one-hour sessions of PEPS and treatment as usual (TAU) will have lower total apathy-avolition and anhedonia-asociality composite scores on the Scale for the Assessment of Negative Symptoms (SANS) than patients who attend only TAU. Eighty participants diagnosed with schizophrenia or schizoaffective disorder were randomized to receive either TAU or PEPS + TAU. The participants were assessed by independent evaluators before randomization (T0), in a post-test after 8 weeks of treatment (T1) and at a 6-month follow-up (T2). The post-test results and 6-month follow-up assessments according to an intention-to-treat analysis showed that the apathy and anhedonia composite scores on the SANS indicated statistically greater clinical improvements in PEPS participants than in non-PEPS participants. In the post-test, anhedonia but not apathy was significantly improved, thus favouring the PEPS condition. These results were sustained at the 6-month follow-up. PEPS is an effective intervention to reduce anhedonia in schizophrenia. PEPS is a short, easy-to-use, group-based, freely available intervention that is easy to implement in a variety of environments (ClinicalTrials.gov ID: NCT02593058). )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/30783071; info:eu-repo/semantics/altIdentifier/eissn/1423-0348; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_53DCAB64149F1; https://serval.unil.ch/notice/serval:BIB_53DCAB64149F; https://www.karger.com/Article/FullText/496479; https://serval.unil.ch/resource/serval:BIB_53DCAB64149F.P002/REF.pdf )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1159/000496479 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://serval.unil.ch/notice/serval:BIB_53DCAB64149F<br />https://doi.org/10.1159/000496479<br />https://www.karger.com/Article/FullText/496479<br />https://serval.unil.ch/resource/serval:BIB_53DCAB64149F.P002/REF.pdf<br />http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_53DCAB64149F1 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/openAccess ; CC BY-NC-ND 4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0/ )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.8622C361 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1159/000496479 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Adult [Type] => general ) [1] => Array ( [SubjectFull] => Anhedonia [Type] => general ) [2] => Array ( [SubjectFull] => Apathy [Type] => general ) [3] => Array ( [SubjectFull] => Cognitive Behavioral Therapy [Type] => general ) [4] => Array ( [SubjectFull] => Female [Type] => general ) [5] => Array ( [SubjectFull] => Humans [Type] => general ) [6] => Array ( [SubjectFull] => Male [Type] => general ) [7] => Array ( [SubjectFull] => Motivation [Type] => general ) [8] => Array ( [SubjectFull] => Pleasure [Type] => general ) [9] => Array ( [SubjectFull] => Psychiatric Status Rating Scales [Type] => general ) [10] => Array ( [SubjectFull] => Schizophrenia/complications [Type] => general ) [11] => Array ( [SubjectFull] => Schizophrenia/therapy [Type] => general ) [12] => Array ( [SubjectFull] => Schizophrenic Psychology [Type] => general ) [13] => Array ( [SubjectFull] => Treatment Outcome [Type] => general ) [14] => Array ( [SubjectFull] => Negative symptoms [Type] => general ) [15] => Array ( [SubjectFull] => Positive psychology [Type] => general ) [16] => Array ( [SubjectFull] => Randomized controlled trial [Type] => general ) [17] => Array ( [SubjectFull] => Schizophrenia [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chaix, J. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pellet, J. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Frobert, L. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Fankhauser, C. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ismailaj, A. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Brana, A. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tamic, G. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Suter, C. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Rexhaj, S. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2019 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Psychotherapy and psychosomatics, vol. 88, no. 2, pp. 84-95 [Type] => main ) ) ) ) ) ) )
IllustrationInfo